Neutralization of excessive levels of active TGF-β1 reduces MSC recruitment and differentiation to mitigate peritendinous adhesion

Abstract

Peritendinous adhesion formation (PAF) can substantially limit the range of motion of digits. However, the origin of myofibroblasts in PAF tissues is still unclear. In this study, we found that the concentration of active TGF-β1 and the numbers of macrophages, mesenchymal stromal cells (MSCs), and myofibroblasts in human and mouse adhesion tissues were increased. Furthermore, knockout of TGF-β1 in macrophages or TGF-β1R2 in MSCs inhibited PAF by reducing MSC and myofibroblast infiltration and collagen I and III deposition, respectively. Moreover, we found that MSCs differentiated into myofibroblasts to form adhesion tissues. Systemic injection of the TGF-β–neutralizing antibody 1D11 during the granulation formation stage of PAF significantly reduced the infiltration of MSCs and myofibroblasts and, subsequently, PAF. These results suggest that macrophage-derived TGF-β1 recruits MSCs to form myofibroblasts in peritendinous adhesions. An improved understanding of PAF mechanisms could help identify a potential therapeutic strategy.

References

[1] Weis C et al. Poly (vinyl alcohol) membranes for adhesion prevention. J. Biomed. Mater. Res. Part B: Appl. Biomater., 2004, 70: 191-202

[2] Ellis H et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet., 1999, 353: 1476-1480

[3] Shalumon K-T et al. Multi-functional electrospun antibacterial core-shell nanofibrous membranes for prolonged prevention of post-surgical tendon adhesion and inflammation. Acta Biomater., 2018, 72: 72121-72136

[4] Nazifi O, Stuart A-L, Nikkhah D. The use of 5-fluorouracil in the prevention of tendon adhesions: a systematic review. Anim. Model Exp. Med., 2020, 3: 87-92

[5] Titan A-L et al. Flexor tendon: development, healing, adhesion formation, and contributing growth factors. Plast. Reconstr. Surg., 2019, 144: 639e-647e

[6] Shi X et al. Prevention of postoperative adhesion reformation by intermittent intrauterine balloon therapy: a randomised controlled trial. BJOG, 2019, 126: 1259-1266

[7] van den Beukel B-A et al. Surgical treatment of adhesion-related chronic abdominal and pelvic pain after gynaecological and general surgery: a systematic review and meta-analysis. Hum. Reprod. Update, 2017, 23: 276-288

[8] Stapleton L-M et al. Use of a supramolecular polymeric hydrogel as an effective post-operative pericardial adhesion barrier. Nat. Biomed. Eng., 2019, 3: 611-620

[9] Feng B et al. Bioresorbable electrospun gelatin/polycaprolactone nanofibrous membrane as a barrier to prevent cardiac postoperative adhesion. Acta Biomater., 2019, 83: 83211-83220

[10] Stommel MWJ et al. Multicenter observational study of adhesion formation after open-and laparoscopic surgery for colorectal cancer. Ann. Surg., 2018, 267: 743-748

[11] Fortin C-N, Saed G-M, Diamond M-P. Predisposing factors to post-operative adhesion development. Hum. Reprod. Update, 2015, 21: 536-551

[12] Ray N-F et al. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J. Am. Coll. Surg., 1998, 186: 1-9

[13] Dy C-J et al. Complications after flexor tendon repair: a systematic review and meta-analysis. J. Hand Surg., 2012, 37: 543-551

[14] Loiselle A-E, Kelly M, Hammert W-C. Biological augmentation of flexor tendon repair: a challenging cellular landscape. J. Hand Surg. Am., 2016, 41: 144-149

[15] Liu C et al. Biological amnion prevents flexor tendon adhesion in zone II: a controlled, multicentre clinical trial. Biomed. Res. Int., 2019, 2019: 2354325

[16] Nichols AEC, Best K-T, Loiselle A-E. The cellular basis of fibrotic tendon healing: challenges and opportunities. Transl. Res., 2019, 209: 156-168

[17] Ishiyama N et al. The prevention of peritendinous adhesions by a phospholipid polymer hydrogel formed in situ by spontaneous intermolecular interactions. Biomaterials, 2010, 31: 4009-4016

[18] Civan O et al. Tenolysis rate after zone 2 flexor tendon repairs. Jt Dis. Relat. Surg., 2020, 31: 281-285

[19] Azari KK, Meals RA. Flexor tenolysis. Hand Clin., 2005, 21: 211-217

[20] Graham D-J et al. The effect of extensor tendon adhesions on finger motion. J. Hand Surg. Am., 2019, 44: 901-903

[21] Breton, A., Dautel G. Finger flexor tenolysis. Chirurgie de la main, 33 Suppl, S48–S57 (2014).

[22] Klass B-R, Rolfe K-J, Grobbelaar A-O. In vitro flexor tendon cell response to TGF-β1: a gene expression study. J. Hand Surg., 2009, 34: 495-503

[23] Best K-T et al. Deletion of NFKB1 enhances canonical NF-kappaB signaling and increases macrophage and myofibroblast content during tendon healing. Sci. Rep., 2019, 9

[24] Kang Y-M et al. Follistatin mitigates myofibroblast differentiation and collagen synthesis of fibroblasts from scar tissue around injured flexor tendons. Yonsei Med. J., 2020, 61: 85-93

[25] Jørgensen H-G et al. Neutralisation of TGFβ or binding of VLA-4 to fibronectin prevents rat tendon adhesion following transection. Cytokine, 2005, 30: 195-202

[26] Liu S et al. Biomimetic sheath membrane via electrospinning for antiadhesion of repaired tendon. Biomacromolecules, 2012, 13: 3611-3619

[27] Hu C et al. Long-term drug release from electrospun fibers for in vivo inflammation prevention in the prevention of peritendinous adhesions. Acta Biomater., 2013, 9: 7381-7388

[28] Liu S et al. Prevention of peritendinous adhesions with electrospun ibuprofen-loaded poly(L-lactic acid)-polyethylene glycol fibrous membranes. Tissue Eng. Part A, 2013, 19: 529-537

[29] Beredjiklian P-K. Biologic aspects of flexor tendon laceration and repair. JBJS, 2003, 85: 539-550

[30] Kvist M et al. Fine structural alterations in chronic Achilles paratenonitis in athletes. Pathol.-Res. Pract., 1985, 180: 416-423

[31] Plikus M-V et al. Regeneration of fat cells from myofibroblasts during wound healing. Science, 2017, 355: 748-752

[32] Lee J-H et al. Erratum to: Specific disruption of Lnk in murine endothelial progenitor cells promotes dermal wound healing via enhanced vasculogenesis, activation of myofibroblasts, and suppression of inflammatory cell recruitment. Stem Cell Res. Ther., 2017, 8: 50

[33] Wong J-KF et al. The cellular biology of flexor tendon adhesion formation: an old problem in a new paradigm. Am. J. Pathol., 2009, 175: 1938-1951

[34] Li M et al. Regulatory effects of dermal papillary pluripotent stem cells on polarization of macrophages from M1 to M2 phenotype in vitro. Transplant. Immunol., 2019, 52: 57-67

[35] Kimura, T. et al. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals. Nat. Commun. 713130 (2016).

[36] Moganti K et al. Hyperglycemia induces mixed M1/M2 cytokine profile in primary human monocyte-derived macrophages. Immunobiology, 2017, 222: 952-959

[37] Khan J, Sharma PK, Mukhopadhaya A. Vibrio cholerae porin OmpU mediates M1-polarization of macrophages/monocytes via TLR1/TLR2 activation. Immunobiology, 2015, 220: 1199-1209

[38] Wang J et al. GTS-21 reduces inflammation in acute lung injury by regulating M1 polarization and function of alveolar macrophages. Shock, 2019, 51: 389-400

[39] Hedl M et al. IRF5 is required for bacterial clearance in human M1-polarized macrophages, and IRF5 immune-mediated disease risk variants modulate this outcome. J. Immunol., 2019, 202: 920-930

[40] Braune J et al. IL-6 regulates M2 polarization and local proliferation of adipose tissue macrophages in obesity. J. Immunol., 2017, 198: 2927-2934

[41] Kimura T et al. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals. Nat. Commun., 2016, 7: 1-17

[42] Oishi S et al. M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T‐cell proliferation. Immunology, 2016, 149: 320-328

[43] Wang X et al. Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice. Nat. Commun., 2018, 9: 1-13

[44] Chang J et al. Studies in flexor tendon wound healing: neutralizing antibody to TGF-β1 increases postoperative range of motion. Plast. Reconstruct. Surg., 2000, 105: 148-155

[45] Tang Y et al. TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med., 2009, 15: 757

[46] Blobe G-C, Schiemann W-P, Lodish H-F. Role of transforming growth factor β in human disease. N. Engl. J. Med., 2000, 342: 1350-1358

[47] Wang X et al. Aberrant TGF-β activation in bone tendon insertion induces enthesopathy-like disease. J. Clin. Investig., 2018, 128: 846-860

[48] Bruno V et al. Effects of low molecular weight heparin on the polarization and cytokine profile of macrophages and T helper cells in vitro. Sci Rep., 2018, 8: 1-9

[49] Han C-H et al. Polarization of macrophages in the blood after decompression in mice. Med. Gas Res., 2017, 7

[50] Consentius C et al. In situ detection of CD73+ CD90+ CD105+ lineage: Mesenchymal stromal cells in human placenta and bone marrow specimens by chipcytometry. Cytom. Part A, 2018, 93: 889-893

[51] Pittenger M-F et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284: 143

[52] Edanami N et al. Characterization of dental pulp myofibroblasts in rat molars after pulpotomy. J. Endod., 2017, 43: 1116-1121

[53] Artlett C-M et al. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum., 2011, 63: 3563-3574

[54] Ackerman JE, Loiselle A-E. Murine flexor tendon injury and repair surgery. J. Vis. Exp., 2016, 115: e54433

[55] Fernando M-R, Giembycz M-A, McKay D-M. Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells. Br. J. Pharmacol., 2016, 173: 899-912

[56] Groszer M et al. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science, 2001, 294: 2186-2189

[57] Khan J-A et al. Fetal liver hematopoietic stem cell niches associate with portal vessels. Science, 2016, 351: 176-180

[58] Mendez-Ferrer S et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature, 2010, 466: 829-834

[59] Ackerman J-E et al. Deletion of EP4 in S100a4-lineage cells reduces scar tissue formation during early but not later stages of tendon healing. Sci. Rep., 2017, 7

[60] Geary M-B et al. Systemic EP4 inhibition increases adhesion formation in a murine model of flexor tendon repair. PLoS One, 2015, 10: e136351

[61] Clausen B-E et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res., 1999, 8: 265-277

[62] Wan M et al. Injury‐activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells, 2012, 30: 2498-2511

[63] Loiselle A-E et al. Bone marrow-derived matrix metalloproteinase-9 is associated with fibrous adhesion formation after murine flexor tendon injury. PloS One, 2012, 7: e40602

[64] Dou C et al. Sialylation of TLR2 initiates osteoclast fusion. Bone Res., 2022, 10: 24

[65] Dakin S-G et al. Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair. PLoS One, 2012, 7: e32333

[66] Tang P-M, Nikolic-Paterson D-J, Lan H-Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat. Rev. Nephrol., 2019, 15: 144-158

[67] Nathan C. Secretory products of macrophages: twenty-five years on. J. Clin. Investis., 2012, 122: 1189-1190

[68] Hui W-W et al. Salmonella enterica Serovar Typhimurium Alters the Extracellular Proteome of Macrophages and Leads to the Production of Proinflammatory Exosomes. Infect. Immun., 2018, 86: e00386-17

[69] Talsma D-T et al. Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathy. Lab. Investig., 2018, 98: 427-438

[70] Katzel E-B et al. Impact of Smad3 loss of function on scarring and adhesion formation during tendon healing. J. Orthop. Res., 2011, 29: 684-693

[71] Kakudo N et al. Effects of transforming growth factor-beta1 on cell motility, collagen gel contraction, myofibroblastic differentiation, and extracellular matrix expression of human adipose-derived stem cell. Hum. Cell, 2012, 25: 87-95

[72] Yang L et al. Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-beta1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis. Am. J. Pathol., 2012, 181: 85-97

[73] Gelberman R-H et al. Combined administration of ASCs and BMP-12 promotes an M2 macrophage phenotype and enhances tendon healing. Clin. Orthop. Relat. Res., 2017, 475: 2318-2331

[74] Cashman J et al. Camptothecin-loaded films for the prevention of postsurgical adhesions. Inflamm. Res., 2004, 53: 355-362

[75] Liu S et al. Tendon healing and anti-adhesion properties of electrospun fibrous membranes containing bFGF loaded nanoparticles. Biomaterials, 2013, 34: 4690-4701

[76] Lee K-H et al. Clinical results of autogenous palmaris longus tendon graft for ruptures of multiple extensors in rheumatoid hands. J. Hand Surg. Am., 2018, 43: 941-947

[77] Cavadas P-C, Thione A, Rubi C. Hand amputations at the radiocarpal level with proximal neuromuscular avulsion. J. Hand Surg. Am., 2016, 41: 70-75

[78] Chytil A et al. Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis, 2002, 32: 73-75

[79] Dasch J-R et al. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J. Immunol., 1989, 142: 1536-1541

[80] Gudemez E et al. Chondroitin sulfate-coated polyhydroxyethyl methacrylate membrane prevents adhesion in full-thickness tendon tears of rabbits. J. Hand Surg. Am., 2002, 27: 293-306

[81] Loiselle A-E et al. Remodeling of murine intrasynovial tendon adhesions following injury: MMP and neotendon gene expression. J. Orthop. Res., 2009, 27: 833-840

[82] Hasslund S et al. Adhesions in a murine flexor tendon graft model: autograft versus allograft reconstruction. J. Orthop. Res., 2008, 26: 824-833

Funding

NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant AR072730